A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Joseph Tauber,1 Barry A Schechter,2 Jason Bacharach,3 Melissa M Toyos,4 Robert Smyth-Medina,5 Sidney L Weiss,6 Jodi I Luchs7 1Tauber Eye Center, Kansas City, MO, USA; 2Florida Eye Microsurgical Institute, Boynton Beach, FL, USA; 3North Bay Eye Associates, Petaluma, CA, USA; 4Toyos Clinic, Nashville...

Full description

Bibliographic Details
Main Authors:	Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Series:	Clinical Ophthalmology
Subjects:	Dry eye disease cyclosporine inflammation Schirmer test
Online Access:	https://www.dovepress.com/a-phase-iiiii-randomized-double-masked-vehicle-controlled-dose-ranging-peer-reviewed-article-OPTH

Similar Items

A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
by: Tauber J, et al.
Published: (2018-12-01)

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]
by: Tauber J, et al.
Published: (2019-01-01)

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
by: Sheppard J, et al.
Published: (2021-01-01)

Efficacy of cyclosporine eyedrop 0.1% in the treatment of dry eye in primary sjogren's syndrome: A prospective Indian study
by: Swapnali Sabhapandit, et al.
Published: (2023-01-01)

A prospective study to assess the role of vitamin D individually and in combination with cyclosporine in the treatment of dry eye in patients with deficient serum 25(OH)D levels
by: Palak Watts, et al.
Published: (2020-01-01)

Ocular Findings of Pediatric Dry Eye Related to Graft-Versus-Host Disease
by: Pınar Bingöl Kızıltunç, et al.
Published: (2021-06-01)

Comparison of topical application of cyclosporine A to prednisolone in treatment of dry eye disease
by: Marwa A Zaky, et al.
Published: (2023-01-01)

Assessment of dry eye using Schirmer test in patients attending a tertiary hospital eye clinic in Nigeria
by: Ibanga AA, et al.
Published: (2024-01-01)

Demographic Profile and Risk Factors for Dry Eye
by: Pragya Basnet, et al.
Published: (2018-06-01)

Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
by: Chang Hyun Park, et al.
Published: (2019-06-01)

The effect of acute exercise on environmentally induced symptoms of dry eye
by: Daniel J. Peart, et al.
Published: (2020-01-01)

Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
by: Paul Karpecki, et al.
Published: (2023-11-01)

Dry eye disease incidence in hemodialysis
by: Stamenković Divna, et al.
Published: (2018-01-01)

Dry Eye among Medical Students of Gandaki Medical College, Pokhara, Nepal
by: S Tuladhar, et al.
Published: (2019-02-01)

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients
by: Miyake H, et al.
Published: (2016-05-01)

Effects of long-term computer use on eye dryness
by: Sezen Akkaya, et al.
Published: (2018-12-01)

Clinical observation of cyclosporine eye drops with artificial tears for dry eyes
by: Xue-Bing Yang, et al.
Published: (2016-05-01)

Prevalence of dry eye in postmenopausal women at a tertiary level hospital
by: Chethana Warad, et al.
Published: (2023-01-01)

Is it Possible to Shorten the Duration of Schirmer Test I?
by: Ömer Faruk Recep
Published: (2012-10-01)

Evaluating of Tear Meniscus Parameters with Optical Coherent Tomography in Dry-Eye Patients
by: Gülizar Soyugelen Demirok, et al.
Published: (2013-08-01)

Prevalence of aqueous deficient dry eye and common ocular surface changes among salt workers
by: Sharanyaa Krishnamoorthy, et al.
Published: (2022-01-01)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
by: Deveney T, et al.
Published: (2018-03-01)

Evaluation of Tear Film Urea Level as a Diagnostic Marker of Dry Eye Disease: A Pilot Study
by: Gurunadh Satyanarayana Velamakanni, et al.
Published: (2022-03-01)

Cyclosporine A (CsA) treatment of chronic autoimune-mediated keratoconjunctivitis sicca in dogs
by: Hadži-Milić M., et al.
Published: (2013-01-01)

Dry Eye Parameters and Lid Geometry in Adults Born Extremely, Very, and Moderately Preterm with and without ROP: Results from the Gutenberg Prematurity Eye Study
by: Achim Fieß, et al.
Published: (2022-05-01)

Dry eye disease related to digital screen exposure in medical students
by: Alka Tripathi, et al.
Published: (2022-01-01)

Topical cyclosporine A for the treatment of dry eye: a randomized clinical study
by: Injy Y ElShazly, et al.
Published: (2021-01-01)

Ferning and Schirmer Test 1 for the Detection of Grading Severity of Dry Eye Syndrome in Post Phacoemulsification Patients
by: Tengku Siti Harilza Zubaidah, et al.
Published: (2022-09-01)

Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation
by: Ritika Mullick, et al.
Published: (2021-01-01)

Daytime Variations of Tear Osmolarity Measurement in Dry Eye Patients
by: Ulviye Yiğit, et al.
Published: (2013-12-01)

Ophthalmological Approach for the Diagnosis of Dry Eye Disease in Patients with Sjögren’s Syndrome
by: Robinson T. Barrientos, et al.
Published: (2022-11-01)

Dry eye disease immune responses and topical therapy
by: Charles W. McMonnies
Published: (2019-04-01)

Xiaoyao Powder combined with tobramycin and dexamethasone in the treatment of dry eye syndrome of Meibomian gland dysfunction
by: Ju Zhao, et al.
Published: (2018-09-01)

Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen
by: Yuan-Hsi Chan, et al.
Published: (2023-01-01)

Optimization and evaluation of tear protein elution from Schirmer's strips in dry eye disease
by: Madhuri Amulya Koduri, et al.
Published: (2023-01-01)

Results of the Schirmer tear test performed with open and closed eyes in clinically normal horses
by: Alexandra Trbolova, et al.
Published: (2017-05-01)

Prevalence of dry eye disease in southern Egypt: a hospital-based outpatient clinic study
by: Engy M Mostafa
Published: (2016-01-01)

Validation of a preclinical dry eye model in New Zealand white rabbits during and following topical instillation of 1% ophthalmic atropine sulfate
by: Alejandra Sánchez‐Ríos, et al.
Published: (2022-06-01)

Impression cytology implicates cell autophagy in aqueous deficiency dry eye
by: Lin T, et al.
Published: (2017-04-01)

A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel
by: Rodriguez-Garcia A, et al.
Published: (2022-04-01)